METHODS: This multicenter study included 894 patients who had undergone RN between 1994 and 2014. Patients with bilateral renal tumors, metastases, preoperative ESRD, and follow-up <1 year were excluded. The primary endpoint was a >30% eGFR decrease from the postoperative baseline, which was defined as eGFR at 1 month after RN. We identified the preoperative risk factors for a >30% eGFR decrease using the Cox proportional hazard model. A riskstratification model incorporating independent risk factors was then generated.
INTRODUCTION AND OBJECTIVES: There is paucity of literature regarding short and long-term renal functional outcomes in patients with chronic kidney disease (CKD) undergoing robotic partial nephrectomy (RPN) . We sought to objectively assess short and long term renal functional outcomes in patients with CKD undergoing RPN for suspicious renal masses.
METHODS: We reviewed a prospectively maintained single surgeon database of patients who underwent RPN between 2010 -2015. 182 patients who had pre-and post-operative (2 and 12 months post-op) MAG-3 renal scans comprised the study cohort. eGFR (in mL/ min/1.73m2) preop and post-op (1 year) was calculated using the MDRD equation. CKD was defined as an eGFR <60 mL/min/1.73m2 (CKD category III & IV). Changes in creatinine, eGFR, and split renal function on renal scan were compared between patients with and without pre-operative CKD. Correlations between pre-op and post-op creatinine and eGFR were also calculated.
RESULTS: Of 182 patients, 30 (16.5%) had CKD. Preop eGFR was 48.5 and 99.0 in the CKD and non-CKD groups, respectively (p <0.001; Table 2 ). Patients with CKD were more likely to have a malignant tumor on pathology (93.3% vs. 73.2%, p¼0.02) and a higher Furhman Grade (3 or more: 49.7% vs 28.1 %, p<0.001). From pre-op to 12 months post-op, eGFR decreased by 2.8 and 1.1 mL/min/1.73m2 (p ¼ 0.6) and the contribution of the surgical kidney on MAG3 renal scan decreased by 5.0 and 4.8% (p ¼ 0.9) in the CKD and non-CKD cohorts, respectively (table 2) . When comparing renal scans at 2 months 12 months of the cohort (figure1), the resected kidney recovered significantly (p<0.001) in both groups in a similar fashion (2.0% in CKD, 1.4% in no CKD p¼0.6)Long-term follow up (median of 2.5 and 3.0 years for CKD and non-CKD groups, respectively) of eGFR change also did not show any difference compared to patients with normal kidney function (-2.8 vs -1.1 mL/min/1.73m2, p¼0.6).
CONCLUSIONS: RPN is a reasonable treatment option in patients with CKD as they did not experience a greater decline in renal function after RPN compared to patients without CKD. The long-term renal functional recovery parallels that of patients without CKD undergoing RPN. Of interest, CKD patients were more likely to have a malignant tumor with a higher Fuhrman grade; a factor to be considered when counseling patients regarding treatment options. . 197, No. 4S, Supplement, Monday, May 15, 2017 
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